Dan Dai Selected Research

Chromosome Aberrations (Chromosome Abnormalities)

2/2009

[Detection of molecular cytogenetic abnormalities in 30 patients with chronic lymphocytic leukemia by fluorescence in situ hybridization].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dan Dai Research Topics

Disease

3	Body Weight (Weight, Body) 01/2022 - 01/2018
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2009 - 04/2009
2	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2022 - 01/2021
2	Fibrosis (Cirrhosis) 01/2021 - 12/2018
2	Non-alcoholic Fatty Liver Disease 01/2021 - 12/2018
2	COVID-19 07/2020 - 01/2020
1	Inflammation (Inflammations) 01/2021
1	Multiple Myeloma 01/2021
1	Neuroinflammatory Diseases 11/2020
1	Stroke (Strokes) 11/2020
1	Critical Illness (Critically Ill) 07/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Plague (Bubonic Plague) 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Diabetes Complications 01/2020
1	Type I Thanatophoric Dysplasia 12/2019
1	Lung Diseases (Lung Disease) 08/2019
1	Interstitial Lung Diseases (Interstitial Lung Disease) 08/2019
1	Hyperoxia 06/2019
1	Hippocampal Sclerosis 05/2019
1	Epilepsy (Aura) 05/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2018
1	Neuroblastoma 09/2017
1	Mood Disorders (Mood Disorder) 09/2017
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2012
1	Leukemia 10/2012
1	Infections 06/2012
1	Chromosome Aberrations (Chromosome Abnormalities) 02/2009

Drug/Important Bio-Agent (IBA)

3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 06/2012
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2019 - 08/2009
2	Capsules (Microcapsules)IBA 01/2021 - 12/2018
2	kangxian ruanganIBA 01/2021 - 12/2018
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 11/2020 - 05/2019
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 07/2020 - 02/2009
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2019
2	fms-Like Tyrosine Kinase 3IBA 10/2009 - 08/2009
1	Methionine (L-Methionine)FDA Link 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Biological ProductsIBA 01/2021
1	Choline (Choline Chloride)IBA 01/2021
1	DesminIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Ferritins (Ferritin)IBA 01/2021
1	trkB ReceptorIBA 11/2020
1	IronIBA 07/2020
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 07/2020
1	C-Reactive ProteinIBA 07/2020
1	fibrin fragment D (D-dimer)IBA 07/2020
1	MyoglobinIBA 07/2020
1	NitrogenIBA 07/2020
1	Urea (Carbamide)FDA LinkGeneric 07/2020
1	LipidsIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	InflammasomesIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	CytokinesIBA 01/2020
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	Ketamine FDA LinkGeneric 01/2020
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 12/2019
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 08/2019
1	Surface-Active Agents (Surfactants)IBA 08/2019
1	Protein CIBA 08/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2019
1	erucylphosphocholineIBA 06/2019
1	Lithium ChlorideIBA 05/2019
1	Phosphates (Orthophosphate)IBA 05/2019
1	Pilocarpine (Ocusert)FDA LinkGeneric 05/2019
1	cordycepinIBA 01/2018
1	Adenosine (Adenocard)FDA LinkGeneric 01/2018
1	AndrogensIBA 09/2017
1	Oxytocin (Pitocin)FDA LinkGeneric 09/2017
1	ElementsIBA 09/2017
1	Androgen Receptors (Androgen Receptor)IBA 09/2017
1	Decitabine FDA Link 10/2012
1	Messenger RNA (mRNA)IBA 06/2012
1	Janus Kinase 2IBA 08/2009
1	NucleophosminIBA 04/2009

Therapy/Procedure

5	Chinese Traditional Medicine (Traditional Chinese Medicine) 03/2022 - 12/2018
3	Therapeutics 01/2021 - 10/2012
2	Aftercare (After-Treatment) 07/2020 - 10/2012